This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: BIG DVA PETM SCTY VAR

Brown-Forman (BF.B) earnings estimates were updated after reporting fourth quarter results, said UBS. FY13 EPS was reduced by $0.02 to $2.70 and FY14 EPS was increased by $0.04 to $3.14. Based on the new FY14 EPS estimate, the price target was increased to $75, said UBS.

Impax Labs (IPXL) earnings estimates were reduced, said UBS. A new 483 warning letter had a lot more extensive issues, leading to uncertainty, said UBS. Price target was reduced to $17.

Newcastle Investment (NCT) earnings estimates were increased through 2014 after reporting fourth quarter results, said UBS. The update includes the announcement to acquire a 50% interest in a consumer loan portfolio from HSBC, said UBS. Price target increased to $14.

Staples (SPLS) earnings estimates through FY2014 were reduced after reporting fourth quarter results, said UBS. Aggressive sales guidance leads to uncertainty and the ODP/OMX merger will over shadow the stock, said UBS. Price target remains $13.

Shares of Time Warner (TWX) now seen reaching $61, according to Credit Suisse. Spin-off of the publishing unit should help unlock value, according to Credit Suisse. Outperform rating.

Exxon Mobil (XOM) earnings estimates were reduced, said UBS. The company provided a weaker than expected production outlook at its analysts meeting, said UBS. Price target remains $91.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BIG $45.92 -0.22%
DVA $73.22 -0.66%
PETM $82.98 0.04%
SCTY $23.63 -11.00%
VAR $81.20 -0.88%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs